Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126768771 | 12676877 | 1 | I | 20160611 | 20160817 | 20160823 | 20160823 | EXP | IT-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-54239IT | BOEHRINGER INGELHEIM | 81.60 | YR | F | Y | 0.00000 | 20160823 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126768771 | 12676877 | 1 | PS | PRADAXA | DABIGATRAN ETEXILATE MESYLATE | 1 | Oral | 220 MG | U | 22512 | 110 | MG | CAPSULE, HARD | BID | |||||
| 126768771 | 12676877 | 2 | C | LACTULOSE. | LACTULOSE | 1 | Oral | 0 | |||||||||||
| 126768771 | 12676877 | 3 | C | DELORAZEPAM | DELORAZEPAM | 1 | Oral | 0 | |||||||||||
| 126768771 | 12676877 | 4 | C | ENTUMIN | CLOTHIAPINE | 1 | Oral | STRENGTH:100 MG/ML, DOSE PER APPLICATION 14 DROPS; | 0 | ORAL SOLUTION | |||||||||
| 126768771 | 12676877 | 5 | C | CONGESCOR | BISOPROLOL | 1 | Oral | 2.5 ANZ | 0 | TABLET | BID | ||||||||
| 126768771 | 12676877 | 6 | C | QUENTIAX | QUETIAPINE FUMARATE | 1 | Oral | 800 MG | 0 | 200 | MG | COATED TABLET | QID | ||||||
| 126768771 | 12676877 | 7 | C | DAFLON | DIOSMINHESPERIDIN | 1 | Oral | 0 | |||||||||||
| 126768771 | 12676877 | 8 | C | QUINAZIL | QUINAPRIL HYDROCHLORIDE | 1 | Oral | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126768771 | 12676877 | 1 | Atrial fibrillation |
| 126768771 | 12676877 | 2 | Constipation |
| 126768771 | 12676877 | 3 | Product used for unknown indication |
| 126768771 | 12676877 | 4 | Schizophrenia |
| 126768771 | 12676877 | 5 | Product used for unknown indication |
| 126768771 | 12676877 | 6 | Schizophrenia |
| 126768771 | 12676877 | 7 | Product used for unknown indication |
| 126768771 | 12676877 | 8 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126768771 | 12676877 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126768771 | 12676877 | Dyspnoea | |
| 126768771 | 12676877 | Gastrointestinal haemorrhage | |
| 126768771 | 12676877 | Haematemesis | |
| 126768771 | 12676877 | Respiratory failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126768771 | 12676877 | 1 | 20151225 | 20160611 | 0 | |
| 126768771 | 12676877 | 4 | 20150522 | 20160611 | 0 | |
| 126768771 | 12676877 | 5 | 20150522 | 20160611 | 0 | |
| 126768771 | 12676877 | 6 | 20150522 | 20160611 | 0 |